Literature DB >> 24723483

Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease.

Sameh Sarray1, Najat Mahdi, Layal R Saleh, Wassim Y Almaoui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24723483     DOI： 10.1002/ajh.23736

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease.

Authors:  Xiaoyu Hu; Ellie H Jhun; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie J Wang
Journal:  Pharmacogenomics       Date:  2016-11-24       Impact factor: 2.533

2.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

3.  Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.

Authors:  Yunfeng Liu; Hui Zhong; Weili Bao; Avital Mendelson; Xiuli An; Patricia Shi; Stella T Chou; Deepa Manwani; Karina Yazdanbakhsh
Journal:  Blood       Date:  2019-05-10       Impact factor: 22.113

Review 4.  Anti-inflammatory cytokines in sickle cell disease.

Authors:  Adekunle E Alagbe; Igor F Domingos; Adekunle D Adekile; Maria H S L Blotta; Magnun N N Santos
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.